For context, tirzepatide's SURMOUNT-OSA trial achieved 50.758.7% AHI reduction retatrutide's 60.6% exceeds that range
Wegovy Treatment Explore effective weight loss options in Bossier City, Louisiana, with Wegovy, a clinically approved treatment making waves nationwide
Research status Reta is Phase 3 investigational
Comparing Your Results to Others Weight loss varies widely due to metabolism, lifestyle, stress, and health factors
Men versus women Men typically lose weight faster than women on tirzepatide, particularly in the first six months
For example, you can take Wellbutrin in the morning to reduce or prevent insomnia, or at night to avoid daytime drowsiness